IP Library Granted Patent US 11,338,063
Granted Patent B2
US 11,338,063 · App. 13/815,747 · Granted May 24, 2022

Placental tissue grafts modified with a cross-linking agent and methods of making and using the same

Inventors: John Daniel (Kennesaw, GA); Randall Spencer (Kennesaw, GA); Brenda Morse (Kennesaw, GA); Thomas J. Koob (Kennesaw, GA); Somaly Sith (Kennesaw, GA)
Assignee: MiMedx Group, Inc.
A61L27/50A61L27/3604A61L27/3675A61L27/3687A61L31/005A61B2017/00884A61B2090/0816A61F2002/009A61L2400/02A61L2430/10A61L2430/14A61L2430/16A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,338,063
App. No.
13/815,747
Granted
May 24, 2022
Kind
B2
Abstract

Described herein are tissue grafts derived from the placenta that possess good adhesion to biological tissues and are useful in wound healing applications. In one aspect, the tissue graft includes (1) two or more layers of amnion, wherein at least one layer of amnion is cross-linked, (2) two or more layers of chorion, wherein at least one layer of chorion is cross-linked, or (3) one or more layers of amnion and chorion, wherein at least one layer of amnion and/or chorion is cross-linked. In another aspect, the grafts are composed of amnion and chorion cross-linked with one another. In a further aspect, the grafts have one or more layers sandwiched between the amnion and chorion membranes. The amnion and/or the chorion are treated with a cross-linking agent prior to the formation of the graft. The presence of the cross-linking agent present on the graft also enhances adhesion to the biological tissue of interest. Also described herein are methods for making and using the tissue grafts.

Claims (38)

1. A dehydrated tissue graft consisting of:

(1) two layers of dehydrated amnion wherein one layer of dehydrated amnion has been treated with a cross-linking agent, or

(2) one layer of dehydrated amnion and one layer of dehydrated chorion, wherein one layer of dehydrated amnion or dehydrated chorion has been treated with a cross-linking agent,

wherein each layer of dehydrated amnion of said dehydrated tissue graft is not decellularized and comprises fibroblast cells and/or epithelial cells, or said layer of dehydrated chorion of said dehydrated tissue graft is not decellularized;

wherein one layer of dehydrated amnion or dehydrated chorion has not been treated with a cross-linking agent;

wherein the dehydrated tissue graft comprises a first external side and a second external side, where the first external side consists essentially of a basement membrane or an epithelial layer and the second external side consists essentially of a fibroblast layer or a chorion layer; and

wherein adjacent layers of dehydrated amnion and/or dehydrated chorion are not cross-linked with one another.

2. The graft of claim 1 , wherein one layer has been treated with a cross-linking agent comprising a sugar.

3. The graft of claim 2 , wherein the sugar comprises D-ribose, glycerose, altrose, talose, ertheose, glucose, lyxose, mannose, xylose, gulose, arabinose, idose, allose, galactose, maltose, lactose, sucrose, cellibiose, gentibiose, melibiose, turanose, trehalose, isomaltose, or any combination thereof.

4. The graft of claim 1 , wherein one layer has been treated with a cross-linking agent comprising a dialdehyde, a carbodiimide, or a combination thereof.

5. The dehydrated tissue graft of claim 1 , wherein either the first external side or the second external side is lightly cross-linked.

6. The dehydrated tissue graft of claim 1 , wherein one or more exposed surfaces of the graft is coated with micronized placental tissue.

7. A method for preventing or reducing scar formation on or near the spine after a surgical procedure, the method comprising applying to a subject a tissue graft of claim 1 directly to the spinal dura of the subject or a region near the spine.

8. The method of claim 7 , wherein the method does not include the use of a suture.

9. A method for treating a dural tear in a subject, the method comprising applying directly to the dural tear a tissue graft of claim 1 .

10. A method for promoting the healing of a wound in a subject, the method comprising applying to the wound the graft of claim 1 , wherein the wound is in the cranial dura, a wound resulting from a perioplastic procedure, for the elimination of a frenum pull, for the regeneration of lost patella tissue, for the repair of the Schneiderian membrane in the sinus cavity, or the soft tissue around dental implants.

11. A method for promoting wound healing associated with a dental surgical procedure, wherein the method comprises contacting the wound with the graft of claim 1 .

12. The method of claim 11 , wherein the graft is used with dental implants, in the treatment of advanced gingival recession defect, or in guided tissue regeneration.

13. A method for promoting wound healing associated with an orthopedic application, wherein the method comprises contacting the wound with the graft of claim 1 .

14. The method of claim 13 , wherein the graft is used in tendon repair, aiding in the repair of periostium, repairing ruptured/damaged bursa, or securing void filling materials during bone repair.

15. A method for promoting wound healing associated with an ENT application, wherein the method comprises contacting the wound with the graft of claim 1 .

16. The method of claim 15 , wherein the ENT application is tympanoplasty, a wound from an adenoidectomy, a wound from a tonsillectomy, or repair of the Sniderian membrane.

17. A method for promoting wound healing involving a subject's extremities, wherein the method comprises contacting the wound with the graft of claim 1 .

18. The method of claim 17 , wherein the graft is an anti-adhesion barrier for small bone fixation, an anti-adhesion barrier where metal plating or hardware is used, or promote the repair of ruptured/damaged bursa.

19. A method for promoting wound healing associated with an ophthalmological application, wherein the method comprises contacting the wound with the graft of claim 1 .

20. A method for promoting wound healing associated with a gynecological application, wherein the method comprises contacting the wound with the graft of claim 1 .

21. The method of claim 20 , wherein the graft is an anti-adhesion barrier after removal of ovarian cyst or aids in the repair of vaginal wall erosion.

22. A method for promoting wound healing associated with an urological application, wherein the method comprises contacting the wound with the graft of claim 1 .

23. The method of claim 22 , wherein the graft facilitates closure of the vas deferens during vasectomy reversal or facilitates closure of the vas deferens resulting from trauma.

24. A method for promoting wound healing associated with general surgery, wherein the method comprises contacting the wound with the graft of claim 1 .

25. The method of claim 24 , wherein the graft facilitates closure of anastomosis, is an anti-adhesion barrier for anastomosis, or is an anti-adhesion barrier for hernia repair.

26. A dehydrated tissue graft consisting of one layer of dehydrated amnion and one layer of dehydrated chorion membrane, wherein the dehydrated amnion and the dehydrated chorion are covalently attached to one another via a cross-linker, and wherein said dehydrated amnion and/or said dehydrated chorion is not decellularized;

wherein one of said dehydrated amnion and said dehydrated chorion has been internally cross-linked by a cross-linking agent;

wherein one of said dehydrated amnion and said dehydrated chorion has not been internally cross-linked by a cross-linking agent; and

wherein the dehydrated tissue graft comprises a first external side and a second external side, where the first external side consists essentially of a basement membrane or an epithelial layer and the second external side consists essentially of a fibroblast layer or a chorion layer.

27. A dehydrated tissue graft consisting of one layer of dehydrated amnion and one layer of dehydrated chorion, wherein one layer of dehydrated amnion and/or dehydrated chorion has been treated with a cross-linking agent, and wherein one layer of dehydrated amnion and/or dehydrated chorion has not been treated with a cross-linking agent, and wherein at least one layer of dehydrated amnion and/or dehydrated chorion is not decellularized; and

wherein the dehydrated tissue graft comprises a first external side and a second external side, where the first external side consists essentially of a basement membrane or an epithelial layer and the second external side consists essentially of a chorion layer; and

wherein said layer of dehydrated amnion and said layer of dehydrated chorion are not cross-linked with one another.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
CORRECTIVE ASSIGNMENT TO CORRECT THE STREET ADDRESS OF THE RECEIVING PARTY: 60 CHASTAIN CENTER BOULEVARD SHOULD READ 60 CHASTAIN CENTER BOULEVARD, "SUITE 60" PREVIOUSLY RECORDED ON REEL 032076 FRAME 0842. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNEE TO BE MIMEDX GROUP, INC.. Recorded Feb 7, 2014
From: DANIEL, JOHN
To: MIMEDX GROUP, INC.
Reel/Frame 032172/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2014
From: DANIEL, JOHN
To: MIMEDX GROUP, INC.
Reel/Frame 032076/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2013
From: SITH, SOMALY
To: MIMEDX GROUP, INC.
Reel/Frame 031261/0716 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2013
From: SPENCER, RANDALL; MORSE, BRENDA; KOOB, THOMAS J.
To: MIMEDX GROUP, INC.
Reel/Frame 031147/0680 →
Continuity (2)
Provisional Application 61683697 · Aug 15, 2012
Related Publication 20140052247A1 · Feb 20, 2014
Cited By (1)
US 12,685,802